Status:
COMPLETED
Endothelial Function, Arterial Stiffness and Components
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions:
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
8-28 years
Brief Summary
Specific Aim: Compare the endothelial function, arterial stiffness and components of metabolic syndrome of childhood Acute Lymphoblastic Leukemia (ALL) survivors to healthy sibling controls. Plan: A c...
Eligibility Criteria
Inclusion
- Survivor:
- Inclusion
- Ages 8-28 (8 is chosen as lower age limit because developmental understanding will allow survivor to follow instructions for procedures, 28 is chosen as upper limit to include age ranges seen for treatment in the pediatric program)
- Off therapy for at least 6 months and not more than 10 years (6 months
- Inclusion
- Biological sibling
- Ages 8-28 (when more than one sibling is available the one closest in age will be chosen.))
Exclusion
- Uncontrolled medical conditions that could interfere with participation or interpretation of results
- History of relapsed ALL or history of bone marrow transplantation
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01439217
Start Date
June 1 2011
End Date
February 1 2013
Last Update
April 17 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
2
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States, 21287